Benzinga | Feb 26, 2021 07:18AM EST

Recro Pharma Q4 EPS $(0.48) Misses $(0.25) Estimate, Sales $9.91M Miss $15.00M Estimate

Recro Pharma (NASDAQ:REPH) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.25) by 92 percent. This is a 26.32 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $9.91 million which missed the analyst consensus estimate of $15.00 million by 33.91 percent. This is a 43.81 percent decrease over sales of $17.64 million the same period last year.